|
Originally published In Press as doi:10.1074/jbc.M206115200 on July 10, 2002
J. Biol. Chem., Vol. 277, Issue 38, 35202-35209, September 20, 2002
New Insights into the Role of the N Terminus in Conformational
Transitions of the Na,K-ATPase*
Laura
Segall ,
Lois K.
Lane§, and
Rhoda
Blostein ¶
From the Department of Biochemistry, McGill
University, Quebec H3G 1A4, Canada and the § Department
of Pharmacology, University of Cincinnati College of Medicine,
Cincinnati, Ohio 45267-0575
The deletion of 32 residues from the N
terminus of the 1 catalytic subunit of the rat Na,K-ATPase (mutant
1M32) shifts the E1/E2 conformational
equilibrium toward E1, and the combination of this deletion
with mutation E233K in the M2-M3 loop acts synergistically to
shift the conformation further toward E1 (Boxenbaum, N.,
Daly, S. E., Javaid, Z. Z., Lane, L. K., and Blostein, R. (1998)
J. Biol. Chem. 273, 23086-23092). To delimit the
region of the cytoplasmic N terminus involved in these interactions,
the consequences of a series of N-terminal deletions of 1 beyond
32 were evaluated. Criteria to assess shifts in conformational
equilibrium were based on effects of perturbation of the entire
catalytic cycle ((i) sensitivity to vanadate inhibition, (ii)
K+ sensitivity of Na-ATPase measured at micromolar ATP,
(iii) changes in K'ATP, and (iv) catalytic turnover), as
well as estimates of the rates of the conformational transitions of
phospho- and dephosphoenzyme (E1P E2P and
E2(K+) E1 + K+).
The results show that, compared with 1M32, the deletion of up to 40 residues ( 1M40) further shifts the poise toward E1. Remarkably, further deletions (mutants 1M46, 1M49, and 1M56) reverse the effect, such that these mutants increasingly resemble the
wild type 1. These results suggest novel intramolecular
interactions involving domains within the N terminus that impact the
manner in which the N terminus/M2-M3 loop regulatory domain interacts with the M4-M5 catalytic loop to effect E1 E2 transitions.
*
This work was supported by operating grants from the
Canadian Institutes of Health Research (Grant MT-3876) and the Quebec Heart and Stroke Foundation (to R. B.), the National Institutes of
Health (Grant HL 49204) (to L. K.), and a predoctoral fellowship from
the Heart and Stroke Foundation of Canada (to L. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Montreal General
Hospital Research Inst., 1650 Cedar Ave., Rm. L11-132, Montreal, Quebec
H3G 1A4, Canada. Tel.: 514-934-1934 (ext. 44501); Fax: 514-934-8332;
E-mail: Rhoda.Blostein@mcgill.ca.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. R. Yingst, T. M. Doci, K. J. Massey, N. F. Rossi, E. Rucker, and R. R. Mattingly
Angiotensin II stimulates elution of Na-K-ATPase from a digoxin-affinity column by increasing the kinetic response to ligands that trigger the decay of E2-P
Am J Physiol Renal Physiol,
April 1, 2008;
294(4):
F990 - F1000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Scanzano, L. Segall, and R. Blostein
Specific Sites in the Cytoplasmic N Terminus Modulate Conformational Transitions of the Na,K-ATPase
J. Biol. Chem.,
November 16, 2007;
282(46):
33691 - 33697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Segall, A. Mezzetti, R. Scanzano, J. J. Gargus, E. Purisima, and R. Blostein
Alterations in the {alpha}2 isoform of Na,K-ATPase associated with familial hemiplegic migraine type 2
PNAS,
August 2, 2005;
102(31):
11106 - 11111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Imagawa, T. Yamamoto, S. Kaya, K. Sakaguchi, and K. Taniguchi
Thr-774 (Transmembrane Segment M5), Val-920 (M8), and Glu-954 (M9) Are Involved in Na+ Transport, and Gln-923 (M8) Is Essential for Na,K-ATPase Activity
J. Biol. Chem.,
May 13, 2005;
280(19):
18736 - 18744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Segall, R. Scanzano, M. A. Kaunisto, M. Wessman, A. Palotie, J. J. Gargus, and R. Blostein
Kinetic Alterations due to a Missense Mutation in the Na,K-ATPase {alpha}2 Subunit Cause Familial Hemiplegic Migraine Type 2
J. Biol. Chem.,
October 15, 2004;
279(42):
43692 - 43696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Imagawa, S. Kaya, and K. Taniguchi
The Amino Acid Sequence 442GDASE446 in Na/K-ATPase Is an Important Motif in Forming the High and Low Affinity ATP Binding Pockets
J. Biol. Chem.,
December 12, 2003;
278(50):
50283 - 50292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Miyakawa-Naito, P. Uhlen, M. Lal, O. Aizman, K. Mikoshiba, H. Brismar, S. Zelenin, and A. Aperia
Cell Signaling Microdomain with Na,K-ATPase and Inositol 1,4,5-Trisphosphate Receptor Generates Calcium Oscillations
J. Biol. Chem.,
December 12, 2003;
278(50):
50355 - 50361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Mahmmoud, G. Cramb, A. B Maunsbach, C. P. Cutler, L. Meischke, and F. Cornelius
Regulation of Na,K-ATPase by PLMS, the Phospholemman-like Protein from Shark: MOLECULAR CLONING, SEQUENCE, EXPRESSION, CELLULAR DISTRIBUTION, AND FUNCTIONAL EFFECTS OF PLMS
J. Biol. Chem.,
September 26, 2003;
278(39):
37427 - 37438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Segall, Z. Z. Javaid, S. L. Carl, L. K. Lane, and R. Blostein
Structural Basis for alpha 1 Versusalpha 2 Isoform-distinct Behavior of the Na,K-ATPase
J. Biol. Chem.,
March 7, 2003;
278(11):
9027 - 9034.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|